These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19999169)

  • 1. PRODUCT: Embeda 20mg/0.8mg.
    Physician Assistant's Prescribing Reference
    JAAPA; 2009 Nov; 22(11):12. PubMed ID: 19999169
    [No Abstract]   [Full Text] [Related]  

  • 2. A morphine/naltrexone combination (Embeda) for pain.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):22-3. PubMed ID: 20336033
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphine sulfate and naltrexone hydrochloride extended release capsules in patients with chronic osteoarthritis pain.
    Katz N; Hale M; Morris D; Stauffer J
    Postgrad Med; 2010 Jul; 122(4):112-28. PubMed ID: 20675975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of EMBEda (morphine sulfate and naltrexone hydrochloride) extended-release capsules: review of postmarketing adverse events during the first year.
    Badalamenti VC; Buckley JW; Smith ET
    J Opioid Manag; 2012; 8(2):115-25. PubMed ID: 22616317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond.
    Ruan X
    Expert Opin Pharmacother; 2011 May; 12(7):999-1001. PubMed ID: 21470064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone and problems in pain management.
    Vickers AP; Jolly A
    BMJ; 2006 Jan; 332(7534):132-3. PubMed ID: 16424470
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing.
    Smith HS
    Expert Opin Pharmacother; 2011 May; 12(7):1111-25. PubMed ID: 21470065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing acupuncture by low dose naltrexone.
    Hesselink JM; Kopsky DJ
    Acupunct Med; 2011 Jun; 29(2):127-30. PubMed ID: 21415049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalmefene, an intravenous alternative to naltrexone for extradural morphine prophylaxis.
    Stuart AL; McDavid AJ
    Reg Anesth; 1997; 22(3):291. PubMed ID: 9168225
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modern pain therapy with dual advantage. Strong analgesia and superior tolerance].
    MMW Fortschr Med; 2009 Apr; 151(18):26. PubMed ID: 19769066
    [No Abstract]   [Full Text] [Related]  

  • 12. Avinza (morphine sulfate extended-release capsules).
    King CR; Khabazian A
    Clin J Oncol Nurs; 2003; 7(4):458-60, 478. PubMed ID: 12929281
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug formulation treats chronic pain.
    Belavic JM
    Nurse Pract; 2010 Jun; 35(6):10-1. PubMed ID: 20479618
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute opioid withdrawal precipitated by ingestion of crushed embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literature.
    Ruan X; Chen T; Gudin J; Couch JP; Chiravuri S
    J Opioid Manag; 2010; 6(4):300-3. PubMed ID: 20862910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tolerated opioid therapy with oxycodone/naloxone. Better quality of life for osteoporosis patients].
    MMW Fortschr Med; 2009 Apr; 151(18):27. PubMed ID: 19769067
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe opioid withdrawal syndrome after a single dose of nalmefene.
    Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy II: narcotic and narcotic-antagonists analgesics.
    Gardier RW
    Dent Clin North Am; 1978 Jan; 22(1):125-41. PubMed ID: 23324
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
    Gibofsky A; Barkin RL
    Am J Ther; 2008; 15(3):241-55. PubMed ID: 18496262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of cancer pain.
    Med Lett Drugs Ther; 1982 Oct; 24(621):95-6. PubMed ID: 6128666
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphine/naltrexone.
    Duggan ST; Scott LJ
    CNS Drugs; 2010 Jun; 24(6):527-38. PubMed ID: 20443648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.